|
1
|
Alphabet Inc. | ||||||
|---|---|---|---|---|---|---|---|
|
2
|
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||
|
3
|
(In millions; unaudited) | ||||||
|
4
|
|||||||
|
5
|
Three Months Ended | ||||||
|
6
|
March 31, | ||||||
|
7
|
2016 | 2017 | |||||
|
8
|
Operating activities | ||||||
|
9
|
Net income | $4,207 | $5,426 | ||||
|
10
|
Adjustments: | ||||||
|
11
|
Depreciation and impairment of property and equipment | 1,155 | 1,287 | ||||
|
12
|
Amortization and impairment of intangible assets | 216 | 216 | ||||
|
13
|
Stock-based compensation expense | 1,494 | 2,009 | ||||
|
14
|
Deferred income taxes | 414 | 613 | ||||
|
15
|
Loss on marketable and non-marketable investments, net | 280 | 68 | ||||
|
16
|
Other | 64 | 8 | ||||
|
17
|
Changes in assets and liabilities, net of effects of acquisitions: | ||||||
|
18
|
Accounts receivable | 818 | 1,267 | ||||
|
19
|
Income taxes, net | 271 | 510 | ||||
|
20
|
Prepaid revenue share, expenses and other assets | 185 | (128) | ||||
|
21
|
Accounts payable | (269) | 103 | ||||
|
22
|
Accrued expenses and other liabilities | (1,064) | (1,868) | ||||
|
23
|
Accrued revenue share | (131) | (74) | ||||
|
24
|
Deferred revenue | 18 | 111 | ||||
|
25
|
Net cash provided by operating activities | 7,658 | 9,548 | ||||
|
26
|
Investing activities | ||||||
|
27
|
Purchases of property and equipment | (2,444) | (2,508) | ||||
|
28
|
Proceeds from disposals of property and equipment
|
16 | 41 | ||||
|
29
|
Purchases of marketable securities | (20,748) | (20,119) | ||||
|
30
|
Maturities and sales of marketable securities | 17,443 | 19,362 | ||||
|
31
|
Purchases of non-marketable investments | (363) | (354) | ||||
|
32
|
Maturities and sales of non-marketable investments
|
42 | 78 | ||||
|
33
|
Cash collateral related to securities lending | (257) | 0 | ||||
|
34
|
Investments in reverse repurchase agreements | 100 | 0 | ||||
|
35
|
Acquisitions, net of cash acquired, and purchases of intangible assets | (34) | (101) | ||||
|
36
|
Proceeds from collection of notes receivable
|
0 | 750 | ||||
|
37
|
Net cash used in investing activities | (6,245) | (2,851) | ||||
|
38
|
Financing activities | ||||||
|
39
|
Net payments related to stock-based award activities | (807) | (1,009) | ||||
|
40
|
Repurchases of capital stock
|
(2,098) | (1,127) | ||||
|
41
|
Proceeds from issuance of debt, net of costs | 3,956 | 0 | ||||
|
42
|
Repayments of debt
|
(3,962) | (18) | ||||
|
43
|
Proceeds from sale of subsidiary shares | 0 | 480 | ||||
|
44
|
Net cash used in financing activities | (2,911) | (1,674) | ||||
|
45
|
Effect of exchange rate changes on cash and cash equivalents | 60 | 191 | ||||
|
46
|
Net increase (decrease) in cash and cash equivalents | (1,438) | 5,214 | ||||
|
47
|
Cash and cash equivalents at beginning of period | 16,549 | 12,918 | ||||
|
48
|
Cash and cash equivalents at end of period | $15,111 | $18,132 | ||||
|
49
|
|||||||